- Reuters•3 hours ago
It is likely to be at least 10 years before any new generation of antidepressants comes to market, despite evidence that depression and anxiety rates are increasing across the world, specialists said on Wednesday. The depression drug pipeline has run dry partly due to a "failure of science" they said, but also due to big pharma pulling investment out of research and development (R&D) in the neuroscience field because the profit potential is uncertain. "I'd be very surprised if we were to see any new drugs for depression in the next decade.
- PR Newswire•3 days ago
INDIANAPOLIS, Jan. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review ...
- Investor's Business Daily•3 days ago
What should investors take away from the JPMorgan Healthcare Conference? Sentiment is "cautiously optimistic."
LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||76.38 - 78.12|
|52 Week Range||64.18 - 84.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||33.67|
|Dividend & Yield||2.08 (2.69%)|
|1y Target Est||N/A|